Studies have shown that adiponectin can be used to improve insulin resistance by reducing the amount of intracellular fat through increased fatty acid oxidation via activating peroxisome proliferator-activated receptor alpha (PPARα) and enhancing insulin receptor substrate (IRS) signaling in skeletal muscle and liver [27,28]. This evidence concerns the gene PPARA and Insulin resistance.